Our data demonstrate the biological role of LZTS2 in tumorigenesis, and implicates the loss of both LZTS2 and PTEN as important biological and relevant events that can directly contribute to prostate cancer development and progression. This evidence concerns the gene PTEN and prostate carcinoma.